New research finds CBD reduces severe lung inflammation associated with Covid-19
Researchers at the University of Nebraska and the Texas Biomedical Research Institute have recently published a peer-reviewed article suggesting that CBD could be included in the treatment regimen for the COVID-19 coronavirus. Researchers say that both THC and CBD appear to reduce the severe lung inflammation associated with the virus.
"Unlike THC, CBD has a high margin of safety and is well tolerated pharmacologically even after treatments of up to 1500 mg/day for two weeks in both animals and humans, which suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/pathology and disease severity," the article said.
The article also suggested that CBD could also help with the psychological stress that comes after a fight with something like the coronavirus.
Researchers at the University of Nebraska and the Texas Biomedical Research Institute have recently published a peer-reviewed article suggesting that CBD could be included in the treatment regimen for the COVID-19 coronavirus. Researchers say that both THC and CBD appear to reduce the severe lung inflammation associated with the virus.
The article also suggested that CBD could also help with the psychological stress that comes after a fight with something like the coronavirus.
No comments:
Post a Comment